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Abstract
Tissue engineering is based on the association of cultured cells with structural matrices and the incorporation of signaling
molecules for inducing tissue regeneration. Despite its enormous potential, tissue engineering faces a major challenge
concerning the maintenance of cell viability after the implantation of the constructs. The lack of a functional vasculature
within the implant compromises the delivery of nutrients to and removal of metabolites from the cells, which can lead to
implant failure. In this sense, our investigation aims to develop a new strategy for enhancing vascularization in tissue
engineering constructs. This study’s aim was to establish a culture of human adipose tissue-derived stem cells (hASCs) to
evaluate the biocompatibility of electrospun fiber mesh made of polyhydroxybutyrate (PHB) and its copolymer poly-3-
hydroxybutyrate-co-3-hydroxyvalerate (PHB-HV) and to promote the differentiation of hASCs into the endothelial lineage.
Fiber mesh was produced by blending 30% PHB with 70% PHB-HV and its physical characterization was conducted using
scanning electron microscopy analysis (SEM). Using electrospinning, fiber mesh was obtained with diameters ranging
300 nm to 1.3 mm. To assess the biological performance, hASCs were extracted, cultured, characterized by flow cytometry,
expanded and seeded onto electrospun PHB/PHB-HV fiber mesh. Various aspects of the cells were analyzed in vitro using
SEM, MTT assay and Calcein-AM staining. The in vitro evaluation demonstrated good adhesion and a normal morphology of
the hASCs. After 7, 14 and 21 days of seeding hASCs onto electrospun PHB/PHB-HV fiber mesh, the cells remained viable
and proliferative. Moreover, when cultured with endothelial differentiation medium (i.e., medium containing VEGF and
bFGF), the hASCs expressed endothelial markers such as VE-Cadherin and the vWF factor. Therefore, the electrospun PHB/
PHB-HV fiber mesh appears to be a suitable material that can be used in combination with endothelial-differentiated cells to
improve vascularization in engineered bone tissues.
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Introduction
Tissue engineering is ‘an interdisciplinary field that applies the
principles of engineering and life sciences toward the development
of biological substitutes that restore, maintain, or improve tissue
function or a whole organ’ [1] . One approach utilized in this area
is based on the fabrication of scaffolds that can be employed as cell
support devices upon which cells are seeded in vitro and able to lay
down a matrix to produce the foundations of a tissue for
transplantation. Growth factors can be introduced to stimulate
cell proliferation and differentiation [2,3].
The need for bone repair in many patients suffering from large
bone resections or significant trauma has led to the development of
bone grafts using tissue-engineering approaches. To become
widely used in clinical practice, bone tissue-engineering products
must overcome a series of challenges, the completely supply of
nutrients and metabolites diffusion being one of the most
important. [4–6]. Indeed, the vascularization of cell-seeded
implants plays an important role in cell survival, as these cells
require access to substrate molecules (oxygen, glucose and amino
acids) and clearance of products of metabolism (CO2, lactate and
urea) [7,8]. Additionally, due to the limitations of oxygen diffusion,
most cells cannot survive at distances greater than or equal to
150 mm from a capillary [4] and blood vessels also have important
metabolic and rheological functions that are organ-specific and
important for the regeneration of tissue [9].
Therefore, as in the development of native bone, vascularization
following implantation is of critical importance for the survival,
integration and functionality of engineered bone tissue [10]. Many
approaches have been proposed to increase vascularization in
bone tissue engineering, including modulation of scaffold archi-
tecture, inclusion of angiogenic growth factors, co-culture systems
and pre-vascularization in vitro [11–17].
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a basement membrane composed of protein fibers at the
nanoscale, such as type IV collagen and laminin fibers. This
natural extracellular matrix (ECM) is critical for the support of the
vascular endothelium by maintaining the organization of vascular
endothelial cells into blood vessels. Furthermore, the endothelial
cells proliferation, migration, morphogenesis, survival and blood
vessel stabilization are dependent on their adhesion to the ECM
[18].
In the biomaterials field, the electrospinning processing
technique allows to produce polymer fibers with diameters in
the range of nanometers to micrometers that are physically
comparable to the collagen fibers found in the natural ECM and
[19,20] has been extensively employed in tissue engineering
strategies [21–26].
Polymeric biomaterials have widely been utilized in biomaterials
research for tissue engineering applications, mainly because of the
great variety of natural and synthetic biodegradable polymers.
[27].
Polyhydroxyalkanoates (PHAs) are naturally polyesters of
hydroxyalkanoic acids that are synthesized by a wide range of
bacteria, generally under unbalanced growth conditions, to act as
carbon and energy reserve materials [28]. PHAs are promising
materials for various applications, including tissue engineering,
because they have useful mechanical properties and are biode-
gradable and biocompatible [29]. In fact, polyhydroxybutyrate
(PHB) and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB-
HV), which are members of PHAs family, degrade in vivo into D-3-
hydroxybutyrate, a normal constituent of human blood [30–32].
Although PHB is inherently biocompatible and biodegradable,
the use of PHB is significantly limited in biomedical applications
by several of its characteristics, including rigidity, brittleness and
low mechanical properties [33,34]. PHB-HV is less crystalline and
more flexible than PHB [35,36]. The combination of these two
polymers could provide a suitable candidate material blend for
bioactive and biodegradable composite implants that would guide
tissue growth and be replaced by newly formed tissue [37].
The aim of the current study was to create an endothelial
network that could improve the vascularization of engineered
bone tissue. To this end, we established a culture of human
adipose tissue-derived stem cells (hASCs) to evaluate the
biocompatibility of electrospun fiber mesh made of PHB and
PHB-HV and to promote the differentiation of hASCs into
endothelial cells.
Results
Morphology of electrospun PHB/PHB-HV fiber mesh
The PHB/PHB-HV fiber mesh was produced by electrospin-
ning from a blend of 30% PHB and 70% PHB-HV. Figure 1A
depicts the top surface of the electrospun fiber mesh. The SEM
image confirmed the possibility of obtaining a mesh-like structure
with 100 mm thickness and composed of randomly distributed
fibers with diameters ranging from 300 nm to 1.3 mm with mean
of 770 nm60,25 (Figure 1B). This structure is similar to that of a
natural ECM.
Isolation and characterization of human adipose tissue-
derived stem cells
Stem cells from the stromal fractions of adipose tissue were
isolated by enzymatic dissociation following centrifugation. The
isolated cells displayed a fibroblastic morphology and were
adherent to plastic. Also, the cells were able to self-renew and
form colonies (data not shown). Isolated stem cells from human
adipose tissue were expanded and their specific surface antigens
were characterized by flow cytometry, which was essential for
ensuring the purity of the cell population. Flow cytometry analysis
indicated that the isolated cell population expressed CD29
(92,33%62,00), CD44 (97,40%61,22), CD73 (96,55%60,76)
and HLA-ABC (91,76%61,45) and was completely isolated from
lymphocytes and hematopoietic stem cells, as the cells did not
express CD34 (0,56%60,35), CD45 (0,11%60,03) and HLA-DR
(0,08%60,04) (Figure 2). This isolated cell population was
designed human adipose tissue-derived stem cells (hASCs).
Cell adhesion and morphology by SEM
Human adipose tissue-derived stem cells (hASCs) were seeded
onto the electrospun fiber mesh and cultured for seven days. The
morphology of the cells was examined by SEM, which indicated
that the cells adhered to and interacted with the fibrous structure
and spread over the surface. The cells exhibited the typical
spindle-shape morphology and cell-to-cell interactions were also
observed (Figure 3).
Cell proliferation and viability
A metabolic activity-based assay (MTT) was performed at
various time points to determine the cells viability and prolifer-
ation when cultured in two types of culture medium: a basal
medium and an endothelial differentiation medium. MTT results
are directly proportional to the number of living cells. The results
indicated that hASCs proliferated in both types of medium since
the absorbance value enhanced from 7 to 21 days (Figure 4A).
When cultured in basal medium, hASC exhibit enhanced
proliferation when seeded on electrospun PHB/PHB-HV fiber
mesh comparing to culture plates. During the endothelial
differentiation, hASCs cultured on electrospun PHB/PHB-HV
fiber mesh proliferate less comparing to hASCs cultured on
electrospun PHB/PHB-HV fiber mesh with basal medium and
hASCs cultured without fiber mesh with endothelial differentiation
medium. When the endothelial differentiation was performed in
cells cultured without the fiber mesh, no difference on the
proliferation comparing with the basal medium was detected
(Figure 4A) Moreover, cell viability assay employing Calcein-AM
staining was performed to ensure the viability and assess the
morphology and distribution of hASCs after 21 days (Figure 4B
and C). These results showed that the cells cultured on electrospun
PHB/PHB-HV fiber mesh with basal medium are well distributed
and the cells cultured on electrospun PHB/PHB-HV fiber mesh
with endothelial differentiation medium rearrange themselves
forming circle-like structures that are characteristic of endothelial
cells organization, mimicking the tubular organization of blood
vessels.
Figure 1. Structure of the electrospun PHB/PHB-HV fiber mesh.
(A) Digital photograph of the electrospun PHB/PHB-HV fiber mesh
surface; (B) SEM micrograph illustrating the disposition of the fibers.
doi:10.1371/journal.pone.0035422.g001
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To analyze the cells differentiation towards the endothelial
phenotype, an immunofluorescence assay was performed to
examine the expression of endothelial markers. The hASCs
cultured with basal medium indicated no specific staining for VE-
Cadherin and vWF when cultured on TCPS coverslips (Figure 5A)
and electrospun PHB/PHB-HV fiber mesh (Figure 5D). After 21
days of culture in endothelial differentiation medium, hASCs
expressed VE-Cadherin and vWF when cultured on TCPS
coverslips (Figure 5B and C) and electrospun PHB/PHB-HV
fiber mesh (Figure 5E and F). When the endothelial induction was
performed on hASCs cultivated on electrospun PHB/PHB-HV
fiber mesh, the cells exhibited tube-like structures that were not
present in hASCs differentiated in TCPS coverslips (Figure 5E and
F). Additionally, the cells that were differentiated on electrospun
PHB/PHB-HV fiber mesh presented enhanced fluorescence
intensity for both markers comparing to cells differentiated on
TCPS coverslip (Figure 5H). For more evidence of endothelial
differentiation, the mRNA expression over time of selected
endothelial marker on hASCs cultured on TCPS and on the
electrospun PHB/PHB-HV fiber mesh was analyzed by RT-PCR.
The results indicated that the mRNA expression of VEGFR2 was
detected in the cells cultured for 21 days in basal medium, but was
upregulated after 21 days in endothelial differentiation medium,
more evidenced in the cells cultured on electrospun PHB-HV fiber
mesh than in TCPS(Figure 6). These results indicate that the cells,
cultured on electrospun PHB-HV fiber mesh successfully differ-
entiated into the endothelial phenotype.
Discussion
Regenerative medicine is based on the possibility of repairing
tissues damaged by disease, trauma or senescence. In tissue
engineering approaches, these repairs may be achieved by
combining the materials field with the life science to create a
construct that can temporarily replace mechanical function, guide
tissue growth and degrade at rates appropriate to tissue
regeneration [1]. Furthermore, for metabolically active tissues,
such as the bone tissue, the vascularization of the construct to be
implanted is crucial for cell survival and the formation of new
tissue [6,38]. Bone growth greatly depends on the vascular
network to supply nutrients, remove metabolites and allow osseous
formation and repair. In large bone grafts, without the proper
blood supply, seeded osteoblasts in the middle of porous scaffolds
are subject to necrosis due to ineffective transportation of oxygen,
nutrients and metabolites and only a shell of bone may be formed
at the surface of the scaffold. In this way, the rate and range of
vascular growth seem to determine the efficiency of new bone
formation. Numerous strategies for vascularization of engineered
bone tissue have been reported, but most involve sophisticated
scaffolds, co-cultures systems and local delivery of angiogenic
Figure 2. Flow cytometry analysis of hASCs. The expression pattern of specific antigens on the surface of the hASCs is depicted with
representative histograms and the expression of each marker. The cell population expressed CD29, CD44, CD73 and HLA-ABC, and did not express
CD34, CD45 and HLA-DR.
doi:10.1371/journal.pone.0035422.g002
Figure 3. SEM micrographs of the morphology of hASCs
cultured for 7 days on the electrospun PHB/PHB-HV fiber
mesh. (A) Panoramic view depicting high cell density and spindle-
shape morphology, scale bar: 100 mm; (B) arrow indicate the interaction
between two and more cells, scale bar: 10 mm; (C–D) arrows indicate
the interaction of hASCs with the fibers, scale bar: 5 mm.
doi:10.1371/journal.pone.0035422.g003
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performed 7, 14 and 21 days after the cell seeding and cultured in two specific medium: the basal medium and the endothelial differentiation
medium. The results are expressed as the means 6 SD, (*) indicating a significant difference with p,0.05, (**) p,0,01, (***) p,0,001; (B) cell viability
after 21 days of cell culture with the basal medium and (C) the endothelial differentiation medium on the electrospun PHB/PHB-HV fiber mesh, as
analyzed by Calcein-AM staining.
doi:10.1371/journal.pone.0035422.g004
Figure 5. Protein expression of hASCs during endothelial differentiation. Confocal images of the expression of the VE-Cadherin (A) and the
vWF factor (B) after 21 days. A.1 and B.1 - hASCs cultured with the basal medium on the TCPS coverslips, A.2 and B.2 - hASCs cultured with the
endothelial differentiation medium on the TCPS coverslips, A.3 and B.3 - hASCs cultured with the basal medium on the electrospun PHB/PHB-HV fiber
mesh, A.4 and B.4 - hASCs cultured with the endothelial differentiation medium on the electrospun PHB/PHB-HV fiber mesh. Scale bar 20 mm. The
images, A.2, A.4, B.2 and B.4 represent the overlay of bright-field and confocal images for visualization of the fiber mesh. (C) Fluorescence intensity of
the expression of VE-Cadherin and the vWF factor in cells differentiated on TCPS coverslip and electrospun PHB/PHB-HV fiber mesh. The results are
expressed as the means 6 SD, (*) significant difference for p,0,05. (a.u): arbitrary units.
doi:10.1371/journal.pone.0035422.g005
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bone grafts in a clinically relevant manner could vastly expand the
utility of engineered bone tissue grafts.
In this study, we developed a fiber mesh made by blending PHB
and PHB-HV using the electrospinning technique. These
polymers are members of the PHA family and are useful for
tissue engineering, due to their biocompatibility and biodegrad-
ability. Various scaffolds made by PHB or PHB-HV have
demonstrated high levels of biocompatibility and cell attachment
with various cell types [39–42]. Electrospinning has been proposed
as a promising technique to produce fiber mesh with fiber
diameters ranging from a few micrometers to the nanometer range
[22]. Sombatmankhong and colleagues [37] successfully fabricated
and characterized PHB/PHB-HV fibers in various compositions.
In contrast to our fiber mesh, that exhibits fibers with diameters
ranging from 300 nm to 1.3 mm, the structures obtained by
Sombatmankhong and colleagues [37] exhibited fibers with
diameters ranging from 1.1 mm to 4.0 mm. The natural extracel-
lular matrix is composed of randomly oriented collagens of
nanometer-scale diameters similar to our structure, which favors
cell adhesion, proliferation and differentiation. It was also reported
the production of electrospun fiber meshes by blending PHB with
other biomaterials, such as chitosan [43] and polyvinyl alcohol
(PVA) [44]. Both fibers showed to be nontoxic and enable for cell
attachment, growth and proliferation.
To assess the biocompatibility of electrospun PHB/PHB-HV
fiber mesh, isolated human adipose tissue cells were expanded and
characterized by flow cytometry. The isolated cell population
exhibited a specific surface antigen expression pattern character-
istic of mesenchymal stem cells, which indicated that these cells are
human adipose-derived stem cells (hASCs) [45–47]. The SEM
images indicated that the hASCs attached to the electrospun
PHB/PHB-HV fiber mesh and spread extensively. The hASCs
were able to interact with the PHB/PHB-HV fibers and with
neighboring cells. The hASCs attached at multiple focal points at
the surface of the fibers, demonstrating that the cells adapted to
this new environment.
The MTT assay is employed to evaluate the cytotoxicity of
various tissue engineering materials, and the absorbance value can
provide an indication of the cells growth and proliferation. When
cultured in basal medium, the hASCs proliferated more on the
electrospun PHB/PHB-HV fiber mesh over an increased culture
time comparing to hASCs cultured on culture plates. This
confirmed that the fiber mesh promotes cell proliferation without
a cytotoxic effect and is a better environment for the cells. The
viability of the cells was confirmed by the Calcein-AM assay. After
21 days, the cells seeded onto the electrospun PHB/PHB-HV fiber
mesh were live cells exhibiting intact membranes. Our results were
in line with those of another study that seeded hASCs onto
electrospun PLA nanofiber [48]. Furthermore, prior studies have
demonstrated that hASCs can grow and proliferate with various
types of biomaterials [49–52]. Thus, hASCs can be considered a
good cell type for a tissue engineering approach, as they are
derived from an abundant and available source and can be
harvested with minimal morbidity. Also, these cells possess the
ability to differentiate into various lineages under specific culture
conditions [46]. Stem cells are a great source of cells for tissue
engineering, due to their capability for self-renewal and potential
for multilineage differentiation. These features are important
because most differentiated progenitor cells are difficult to obtain
and possess limited capacities for proliferation [53].
In this study, hASCs seeded on electrospun PHB/PHB-HV
fiber mesh were induced to differentiate into the endothelial
lineage with the purpose of obtaining endothelial cells for
enhancing the vascularization of bone grafts. The ability of
hASCs to differentiate into endothelial cells was previously
reported [54,55]. We employed a specific medium to induce the
differentiation and the MTT assay was performed to determine if
the cells were viable and proliferative in the presence of the
endothelial differentiation medium. MTT tests indicated that the
cells cultured on electrospun PHB/PHB-HV fiber mesh prolifer-
ated in the presence of the endothelial medium, but the basal
medium was significantly more effective in stimulating cell
proliferation Research has demonstrated that the capacity to
self-renew is unique to stem cells, and, as the differentiation stages
increase, the proliferative potential diminishes [56]. Mature cells
are unable to proliferate; however, the majority of lineages have a
precursor or committed-progenitor stage in which proliferation
and differentiation are balanced [57,58]. The results indicated that
the cells proliferate less in endothelial differential medium, and the
proliferation was even less when the cells were cultured on the
fiber mesh comparing to TCPS, suggesting that the electrospun
PHB/PHB-HV was helping the compromise of the cells to the
endothelial lineage. Although the cells in the differentiation
medium proliferated less than those in the basal medium, the
cells that were on the electrospun PHB/PHB-HV fiber mesh
surface after 21 days were still viable, as demonstrated by the
Calcein-AM assay.
In our differentiation system, the hASCs expressed endothelial
markers, such as the vWF factor and VE-Cadherin. These markers
are generally expressed when mesenchymal stem cells are induced
to endothelial differentiation with medium containing VEGF and
bFGF [54,59]. Additionally, the expressions of those markers were
enhanced on the cells cultured on electrospun PHB/PHB-HV
fiber mesh. These expression are important for maintain the
endothelial cells functions. VWF factor mediate the adhesion of
blood platelets at sites of vascular injury and stabilizes clotting
factor VIII. Also, vWF may help to anchor endothelial cells to
ECM [60]. VE-Cadherin is a strictly endothelial specific adhesion
molecule located at junctions between endothelial cells and plays
an important role in the maintenance and control of endothelial
cells contacts permitting the formation of a mature and stable
vascular network [61].
Furthermore, the cells that were seeded onto the electrospun
PHB/PHB-HV fiber mesh, when induced to endothelial differen-
tiation, spread randomly and formed interconnected clusters with
delineated of circular spaces among them. This capillary-like
Figure 6. RT-PCR analysis of VEGFR2 mRNA expression during
endothelial differentiation on the electrospun PHB/PHB-HV
fiber mesh and TCPS. Total RNA was extracted from cells cultured on
basal medium and endothelial differentiation medium for analysis of
VEGFR2 mRNA expression. The cells were cultivated up to 21 days.
doi:10.1371/journal.pone.0035422.g006
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are cultivated in specialized conditions that mimics ECM
structure, i.e collagen I gel supplemented with laminin [62], fibrin
gel [63,64], self-assembling peptide scaffold [65] and organotypic
membrane systems [66]. These studies demonstrate that the
capillary development depends on the interactions between
endothelial cells and matrix proteins or biomaterials. In this sense,
the structure of electrospun PHB/PHB-HV fiber mesh, that
mimics the nanofiber structure of ECM can be favoring the
endothelial differentiation.
Additionally, the differentiation of hASCs with VEGF also
upregulates the expression of the VEGF receptor 2 (KDR), which
plays a major rule in the in vivo angiogenesis and contributes, also,
with matrix-metalloproteinase to the formation of capillary-like
structures in vitro [59]. In resume, the differentiation results
indicates that the structure of electrospun PHB/PHB-HV fiber
mesh associated with specific growth factor, VEGF and bFGF, can
improve the endothelial differentiation of hASCs. It has been
reported the use of electrospinning technique as a good choice for
developing structures for vascular tissue engineering. Many types
of biomaterials, such as poly(l-lactide-co-e-caprolactone), poly-
caprolactone and silk, have been processed and have good
properties that supports the attachment and proliferation of
differently sources of endothelial cells [67–71]. However, these
works use only endothelial cells and we demonstrated the
possibility of stimulating the endothelial differentiation from
hASCs. This enables the use of an autologous and proliferative
source of cells.
In conclusion, this study demonstrated that the electrospun
PHB/PHB-HV fiber mesh is a suitable and biocompatible
material that can be employed in combination with endothelial
differentiated cells. This new construct can be used for enhancing
vascularization in engineered bone tissue. The differentiation of
cells on the fiber mesh surface is interesting because the process
can be conducted separately from other types of differentiation,
which could prevent nonspecific differentiation. Furthermore,
studies in vivo need to be performed to verify the efficiency of this
new approach.
Materials and Methods
Preparation of polymers scaffolds
The PHB and PHB-HV polymers were obtained through the
fermentation of sugar cane syrup from Ralstonia eutropha bacteria.
The polymers were produced by PHB Industrial S.A. (PHBISA),
Usina da Pedra, Serrana-SP, Brazil. The PHB/PHB-HV fiber
mesh was produced in the 3B’s Research Group - Portugal by
the polymer processing technique named electrospinning. PHB
and PHB-HV were dissolved in chloroform/dimethylformamide
(30:70) at a concentration of 5% (w/v). The resulting polymer
solution was placed into a 5 ml syringe, which was fitted with a
metallic needle having an internal diameter of 0.8 mm. The
syringe was connected to a syringe pump (KDS100, KD
Scientific) to control the flow rate. A positive electrode was
connected to the needle. A flat aluminum sheet covering the
ground plate was employed as the collector. A high voltage
power supply was employed to generate the electrostatic field (0–
25 kV). The capillary tip-to-collector distance and the flow rate
were 15 cm and 1 ml/h, respectively. The applied voltage was
9 kV. The conditions for the electrospinning were optimized to
obtain a continuous process and reproducible mesh morphology.
The scaffolds were sterilized with c irradiation from a Co
60
source at 15 kGy, and the surface morphology was examined by
scanning electron microscopy (Leica Cambridge S360 micro-
scope). The SEM images of three different samples were
analyzed using ImageJ software to determine the thickness and
fiber diameter.
Isolation of ASC from human adipose tissue
Human adipose tissue was obtained with written informed
consent from healthy patients who had undergo liposuction
surgery for an esthetic reasons in the ‘‘Plastic Surgery Center –
Dr. Luiz Alberto Lamana’’ in Belo Horizonte, Minas Gerais,
Brazil. The liposuction tissue was collected after obtaining
informed consent from the patients according to procedures
approved by Ethics Committee of Federal University of Minas
Gerais. No diabetes, hepatitis, metabolic diseases, or other
systemic complications were reported for these donors. The
isolation and culture of human adipose tissue-derived stem cells
(hASCs) was performed as described by Zuk [45]. Briefly, adipose
tissues were washed with phosphate-buffered saline (PBS), and
the extracellular matrix was digested with 0.15% type I
collagenase for two hours and centrifuged at 1400 rpm for
10 min to obtain a pellet, which was incubated for two days at
37uC/5% CO2 atmosphere in DMEM (Dulbecco’s Modified
Eagle Medium) supplemented with 10% fetal bovine serum
(FBS), 100 U/mL penicillin and 100 U/mL streptomycin (Basal
medium). Following incubation, the tissue culture plates were
washed to remove residual non-adherent cells and were
maintained at 37uC/5% CO2 in the control medium and were
cultured for 7 to 10 days until they reached confluence. The
medium was changed every two days. The cells were then
harvested by digestion with 0.05% trypsin-EDTA, centrifuged at
1400 rpm for 5 minutes, suspended in culture medium, and
plated at a density of approximately 2610
4 cells/cm
2. Cells were
utilized at passage 4.
Flow cytometry analysis
The cell surface antigens specific to hASCs were characterized
by flow cytometry. Cells were harvested and washed with PBS.
Approximately 5610
5 cells were incubated for 30 min at 4uC
with the following primary antibodies: mouse anti-human CD29
(Santa Cruz Biotechnology), CD34 (Abcam), CD44 (Santa Cruz
Biotechnology), CD45 (BD Bioscience), CD73 (PE-conjugated,
BD Bioscience), HLA-ABC (FITC-conjugated, Abcam) and
HLA-DR (FITC-conjugated, Abcam). After washing, the cells
were incubated with a secondary antibody, the FITC-labeled
anti-mouse IgG (Calbiochen), for 30 min at 4uC, washed again
and suspended in PBS. As a control, cells were incubated with
only the secondary antibody to exclude nonspecific binding.
Quantitative analysis was performed using a FACScan argon
laser cytometer (Becton Dickson, San Jose, CA). For each sample,
15.000 events were acquired and analyzed with the CELL
QUEST software. Cell surface marker expression was deter-
mined by comparison with the isotype control on a histogram
plot and data analysis was performed using WinMid 2.8 analysis
software.
Cell seeding
The hASCs at the passage 4 were seeded at a density of 1610
5
cells onto the electrospun PHB/PHB-HV fiber mesh with 1 cm
2
and onto TCPS coverslip that had previously been placed in 24
well culture plates. The cells were allowed to attach to the
substrates for 1 h, then 1 ml of fresh culture medium was added to
each well. After, the cells were incubated in a humidified
atmosphere at 37uC and 5% CO2.
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microscopy (SEM)
In order to examine the morphology of hASCs, the cells were
cultured for 7 days on the electrospun PHB/PHB-HV fiber mesh
and the constructs prepared for SEM analysis. Basically, the
samples were washed twice with PBS and fixed with 2.5%
glutaraldehyde in 0.1 M sodium cacodylate buffer for 2 h, post-
fixed in 1% osmium tetroxide for 2 h, dehydrated in increasing
concentrations of ethanol (from 30%, 40%, 50%, 60%, 70%, 80%
90%, and 95% to 100%) and were critical point-dried. Next, the
samples were mounted on aluminum stumps, coated with gold and
examined with a scanning electron microscope at 15 KV (JEOL/
JSM-6360LV from the Department of Metallurgy – UFMG).
Cellular viability and proliferation
The viability and proliferation of the hASCs on electrospun
PHB/PHB-HV fiber mesh was determined by the tetrazolium salt
MTT (3-[4,5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bro-
mide) assay, which is based on the reduction of tetrazolium salt to
formazan crystals by the dehydrogenase present in living cells
mitochondria [39]. At various culture times 7, 14 and 21 days after
cell seeding, the medium was removed and 210 ml of fresh culture
media and 170 ml of MTT solution (5 mg/mL in PBS) were added
to each well, followed by incubation for 2 h at 37uC in a 5% CO2
atmosphere. The resulting formazan salts were solubilized with
210 mL of SDS-10% HCl (sodium dodecyl sulfate – hydrochloric
acid) for 18 h at 37uC in a 5% CO2 atmosphere, and the optical
density of the solution was evaluated with a microplate
spectrophotometer at 595 nm. Cells cultured without the scaffold
were employed as the control for the proliferation experiment,
which evaluated the proliferation of the hASCs cultured with the
basal medium and the endothelial differentiation medium.
Morphology and distribution
For the assessment of the cell morphology and distribution and
viability, hASCs were seeded onto electrospun PHB/PHB-HV
fiber mesh at various time point over 7, 14 and 21 days and were
incubated for 20 min in Tyrode’s Hepes buffer (140 mmol/l
NaCl, 0.34 mmol/l Na2HPO4, 2.9 mmol/l KCl, 10 mmol/l
Hepes, 12 mmol/l NaHCO3, 5 mmol/l glucose, pH 7.4) con-
taining 0.1 mM Calcein Acetoxymethylester (Calcein-AM). Cal-
cein-AM is a non-fluorescent, cell-permeant compound that is
hydrolyzed by intracellular esterases into the fluorescent anion
calcein. The Calcein-AM stained scaffold was placed on a
microscope slide and visualized through confocal microscopy
(Zeiss LSM 510 Meta). The cellular viability was evaluated for
cells cultured with the basal medium and the endothelial
differentiation medium.
Endothelial cell differentiation
The hASCs growing on electrospun PHB/PHB-HV fiber mesh
scaffolds and on tissue culture polystyrene (TCPS) coverslips were
induced to differentiate into the endothelial lineage by culturing
with DMEM medium containing 2% FBS, 50 ng/mL VEGF and
10 ng/mL bFGF. The cells were cultivated for 7, 14 and 21 days
in a humidified atmosphere at 37uC and 5% CO2. The medium
was changed every two days.
Immunofluorescence
After 21 days of endothelial differentiation, the cells were
analyzed by immunofluorescence for the presence of endothelial
cell markers. The cells were fixed with 4% paraformaldehyde for
15 min at room temperature (RT). Samples were then rinsed with
0.1% Triton for 10 min at RT. After washing with PBS, the
samples were incubated overnight at 4uC with 1:100 dilution of
mouse anti-human vWF (VW92-3, Abcam) and 1:20 dilution of
FITC-labeled rabbit polyclonal anti-human VE-Cadherin (Ab-
cam) primary antibodies. Following PBS washing, the samples that
were incubated with the vWF antibody were next incubated with
the anti-mouse Alexa Fluor 488 (Molecular Probes) secondary
antibody for 1 h at RT. The nuclei were counterstained with
0.2 mg/mL Hoechst in PBS for 20 min. Next, the cells were
washed with PBS, mounted and visualized through confocal
microscopy (Zeiss LSM 510 Meta). The fluorescence intensity was
calculated by measuring the intensity of the pixels using ImageJ
software. The images were analyzed only in the green channel.
Using ROI manager, a region was drawn around each cell to be
measured, and other region with no fluorescence was drawn to be
used for background subtraction. The mean of the intensity of the
pixels of each cell was subtracted from the mean of the
background and plotted on a graph, using GraphPad Prism 5.0.
Each bar represents an average of 15 cells in three different
regions.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
RT-PCR was performed to evaluate the relative mRNA levels
expressed by the receptor of VEGF type 2 (VEGFR2) gene. Total
cellular RNA was extracted from hASCs cultured on TCPS and
PHB/PHB-HV fiber mesh up to 21 days (basal medium and
differentiation medium) with Trizol (Invitrogen), as described by
the manufacturer. Total RNA was treated with the RevertAid
TM
H Minus M-MuLV RT (Fermentas) to generate cDNA using an
oligo(dT) adapter primer. Next, PCR amplification was performed
for VEGFR2 and GAPDH cDNA. The primers used were
VEGFR2 forward: 59GGAATACCCCTTGAGTCC39,
VEGFR2 reverse: 59CCTCCAACTGCCAATACC39, GAPDH
forward: 59GGTATCGTGGAAGGACTCATGAC39 and
GAPDH reverse: 59ATGCCAGTGAGCTTCCCGTTCAGC
39. The PCR cycles were as follows: 94uC for 2 min, 94uC for
30 s, 56uC for 45 s and 72uC for 45 s (30 cycles), 72uC for 10 min.
The RT-PCR products were analyzed through 1% agarose gel
electrophoresis and visualized with ethidium bromide.
Statistical analysis
All experiments were repeated 3 times in triplicate, and the data
were presented as the mean 6 SD. Statistical comparisons were
performed using two-way analysis of variance (ANOVA) and
Bonferroni’s post-hoc test. P-values,0.05 were considered to be
statistically significant.
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